MERCK & CO INC
10-Q, EX-27, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: MERCK & CO INC, 10-Q, EX-12, 2000-11-13
Next: MEREDITH CORP, 10-Q, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED STATEMENT OF INCOME FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000
AND THE CONSOLIDATED BALANCE SHEET AS OF SEPTEMBER 30, 2000 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                           1,535
<SECURITIES>                                     1,300
<RECEIVABLES>                                    4,571
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                      3,100
<CURRENT-ASSETS>                                11,600
<PP&E>                                          16,090
<DEPRECIATION>                                 (5,168)
<TOTAL-ASSETS>                                  38,008
<CURRENT-LIABILITIES>                            8,920
<BONDS>                                          3,438
                                0
                                          0
<COMMON>                                            30
<OTHER-SE>                                      13,490
<TOTAL-LIABILITY-AND-EQUITY>                    38,008
<SALES>                                         28,896
<TOTAL-REVENUES>                                28,896
<CGS>                                           15,873
<TOTAL-COSTS>                                   15,873
<OTHER-EXPENSES>                                 1,682
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                                 355
<INCOME-PRETAX>                                  7,313
<INCOME-TAX>                                     2,256
<INCOME-CONTINUING>                              5,057
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     5,057
<EPS-BASIC>                                       2.19
<EPS-DILUTED>                                     2.15
<FN>
<F1>NOT MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission